Trade Summary

Yesterday, Sukhtian Faisal Ghiath, serving as Dir at Outlook Therapeutics, Inc. (OTLK), purchased 122,174 shares at $0.41 per share, for a total transaction value of $50,005.82. Following this transaction, Sukhtian Faisal Ghiath now holds 125,574 shares of OTLK.

This purchase represents a 3593.35% increase in Sukhtian Faisal Ghiath's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 27, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 3:29 PM ET, meaning the disclosure happened on the same day as the trade.

Outlook Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.